3Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med, 1989, 82 : 203-205. 被引量：1
4Cardiovascular Disease Educational and Research Trust, Cyprus Cardiovascular Disease Educational and Research Trust, European Venous Forum, et al.Prevention and treatment of venous thromboembolism. International Consensus statement (guidelines according to scientific evidence). Int Angiol, 2006, 25: 101-161. 被引量：1
5Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromhoembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med, 1999, 341: 793-800. 被引量：1
6Leizorovicz A, Mismetti P. Preventing venous thromboembolism in medical patients. Circulation, 2004, 110 Suppl 1: Ⅳ13-Ⅳ19. 被引量：1
7Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial. BMJ, 2006, 332: 325-329 被引量：1
8Fraisse F, Holzapfel L, Couland JM, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Am J Respir Crit Care Med, 2000, 161: 1109-1114. 被引量：1
9Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA, 1995, 274: 335-337. 被引量：1
10Spyropoulos AC. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients. Chest, 2005, 128: 958-969. 被引量：1
4Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest, 2001,119 : S132-175. 被引量：1
5Moser KM, LeMoine JR, Nachtwey FJ, et al. Deep venous thrombosis and pulmonary embolism: frequency in a respiratory. intensive care unit. JAMA, 1981,246 : 1422-1424. 被引量：1
6Cade JF. High risk of the critically ill for thromboembolism. Crit Care Med, 1982,10 : 448-450. 被引量：1
7Goldberg SK, Lippmann ML, Walkenstein MD, et al. The prevalence of DVT among patients in respiratory failure: the role of DVT prophylaxis [abstract]. Am J Respir Crit Care Med, 1996,153 : A94. 被引量：1
8Kapoor M, Kupfer YY, Tessler S. Subcutaneous heparin prophylaxis significantly reduces the incidence of venous thromboembolic events in the critically ill [ abstract ]. Crit Care Med, 1999,27 Suppl : $69. 被引量：1
9Fraisse F, Holzapfel L, Couland JM, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. Am J Respir Crit Care Med,2000,161 : 1109-1114. 被引量：1
10Sehonhofer B, Kohler D. Prevalence of deep-vein thrombosis of the leg in patients with acute exacerbation of chronic obstructive pulmonary disease. Respiration, 1998,65(3) : 173-177. 被引量：1
7Ismail K, Aoun E, Sleiman Zade Asfahani W, et al. Abstracts from XIX international ISTH. Congress J Thromb an Haemost,2003,1: 12-18. 被引量：1
8Stein PD, Hull RD, Patel KC, et al. Venous thromboembolic disease comparison of the diagnostic process in men and women. Arch Intern Med, 2003, 163:1689-1694. 被引量：1
9Williams MT,Aravindan N. Phil M, et al. Venous thromboembolism in the intensive care unit. Crit Care Clin,2003,19:185-207. 被引量：1
10Simpson EL,Lawrenson RA, Nightingale AL, et al. Venous thromboembolism in pregnancy and lhe puerperium: incidence and additional risk factors from a London perinatal database. Br J Obstet Gynaecol,2001,108: 56-60. 被引量：1
